Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$2.5 - $5.19 $1.37 Million - $2.84 Million
-547,628 Reduced 13.78%
3,425,202 $8.56 Million
Q3 2021

Nov 15, 2021

BUY
$4.82 - $8.46 $7.91 Million - $13.9 Million
1,641,296 Added 70.4%
3,972,830 $20.3 Million
Q4 2020

Feb 24, 2021

SELL
$10.34 - $13.77 $5.41 Million - $7.2 Million
-523,203 Reduced 18.33%
2,331,534 $25.3 Million
Q3 2020

Nov 19, 2020

BUY
$11.73 - $16.25 $6.14 Million - $8.5 Million
523,203 Added 22.44%
2,854,737 $34.1 Million
Q4 2019

Feb 14, 2020

BUY
$9.77 - $24.6 $22.8 Million - $57.4 Million
2,331,534 New
2,331,534 $57.4 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.